{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T08:25:25Z","timestamp":1766305525613},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.therap.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T08:26:22Z","timestamp":1696407982000},"page":"453-459","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cutaneous adverse effects of antiepileptic drugs"],"prefix":"10.1016","volume":"79","author":[{"given":"Fatma","family":"Zgolli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Aouinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ons","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Widd","family":"Kaabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riadh","family":"Daghfous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarrah","family":"Kastalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghozlane","family":"Lakhoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihem El","family":"Aidli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2023.09.005_bib0210","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.3928\/00904481-20150203-10","article-title":"Antiepileptic drugs a review","volume":"44","author":"Sankaraneni","year":"2015","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.therap.2023.09.005_bib0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00406-017-0827-5","article-title":"Use and safety of antiepileptic drugs in psychiatric inpatients data from the AMSP study","volume":"268","author":"Druschky","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.therap.2023.09.005_bib0220","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2165\/00003495-200767090-00003","article-title":"Antiepileptic drugs in the treatment of neuropathic pain","volume":"67","author":"Eisenberg","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.therap.2023.09.005_bib0225","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol"},{"year":"2010","series-title":"Analyse des notifications des effets ind\u00e9sirables de la carbamaz\u00e9pine","author":"Cherif","key":"10.1016\/j.therap.2023.09.005_bib0230"},{"year":"2014","series-title":"Analyse des notifications des effets ind\u00e9sirables de l\u2019acide valproique. \u00c0 propos de 47 cas","author":"Ben Abda","key":"10.1016\/j.therap.2023.09.005_bib0235"},{"year":"2016","series-title":"Les effets ind\u00e9sirables de la lamotrigine","author":"Aouinti","key":"10.1016\/j.therap.2023.09.005_bib0240"},{"year":"2015","series-title":"DRESS syndrome \u00e0 la carbamaz\u00e9pine. Analyse de 34 notifications","author":"Riahi","key":"10.1016\/j.therap.2023.09.005_bib0245"},{"key":"10.1016\/j.therap.2023.09.005_bib0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.therap.2016.02.010","article-title":"Causality assessment in pharmacovigilance: the French method and its successive updates","volume":"71","author":"Miremont-Salam\u00e9","year":"2016","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2023.09.005_bib0255","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.revmed.2014.10.004","article-title":"Toxidermies","volume":"36","author":"Lebrun-Vignes","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.therap.2023.09.005_bib0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbspin.2013.05.002","article-title":"DRESS syndrome","volume":"81","author":"Descamps","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.therap.2023.09.005_bib0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00228-019-02678-1","article-title":"Safety aspects of antiepileptic drugs a population-based study of adverse effects relative to changes in utilisation","volume":"75","author":"Baftiu","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2023.09.005_bib0270","first-page":"187103","article-title":"Sex differences in drug disposition","volume":"2011","author":"Soldin","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.therap.2023.09.005_bib0275","doi-asserted-by":"crossref","first-page":"e0131","DOI":"10.1371\/journal.pone.0131566","article-title":"Comparative long term effectiveness of a monotherapy with five antiepileptic drugs for focal epilepsy in adult patients: a prospective cohort study","volume":"10","author":"Zeng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.therap.2023.09.005_bib0280","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40261-019-00754-z","article-title":"Adverse cutaneous drug reactions associated with old- and new-generation antiepileptic drugs using the Japanese pharmacovigilance database","volume":"39","author":"Hosohata","year":"2019","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.therap.2023.09.005_bib0285","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3346\/jkms.2020.35.e17","article-title":"Adverse skin reactions with antiepileptic drugs using korea adverse event reporting system database, 2008\u20132017","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.therap.2023.09.005_bib0290","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/epi.14591","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: an analysis of the US food and drug administration adverse event reporting system","volume":"59","author":"Borrelli","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.therap.2023.09.005_bib0295","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.therap.2023.09.005_bib0300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/jiaomr.jiaomr_126_18","article-title":"Drug-induced bullous pemphigoid a case report with review","volume":"30","author":"Rawson","year":"2018","journal-title":"J Indian Acad Oral Med Radiol"},{"key":"10.1016\/j.therap.2023.09.005_bib0305","first-page":"191","article-title":"Gabapentin-induced bullous pemphigoid","volume":"117","author":"Zachariae","year":"2017","journal-title":"J Am Osteopath Assoc"},{"key":"10.1016\/j.therap.2023.09.005_bib0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/15569527.2012.725444","article-title":"A case of levetiracetam induced bullous pemphigoid","volume":"32","author":"Karadag","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"year":"2019","series-title":"La pustulose exanth\u00e9matique aigu\u00eb g\u00e9n\u00e9ralis\u00e9e: diagnostic clinique et imputabilit\u00e9 m\u00e9dicamenteuse","author":"Harbaoui","key":"10.1016\/j.therap.2023.09.005_bib0315"},{"key":"10.1016\/j.therap.2023.09.005_bib0320","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ajem.2017.02.017","article-title":"Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use","volume":"35","author":"Levy","year":"2017","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.therap.2023.09.005_bib0325","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.therap.2023.09.005_bib0330","series-title":"StatPearls [Internet]","article-title":"Exfoliative dermatitis (Erythroderma)","author":"Austad","year":"2023"},{"key":"10.1016\/j.therap.2023.09.005_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3315\/jdcr.2016.1222","article-title":"Erythroderma. A clinical and etiological study of 103 patients","volume":"10","author":"C\u00e9sar","year":"2016","journal-title":"J Dermatol Case Rep"},{"issue":"7","key":"10.1016\/j.therap.2023.09.005_bib0340","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1468-3083.2009.03526.x","article-title":"Acqui155red erythroderma in adults: a clinical and prognostic study","volume":"24","author":"Khaled","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.therap.2023.09.005_bib0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00023210-199912030-00005","article-title":"Anticonvulsant-induced cutaneous reactions: incidence, mechanisms and management","volume":"12","author":"Ruble","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1016\/j.therap.2023.09.005_bib0350","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0190-9622(95)91271-1","article-title":"Cutaneous photosensitivity diseases induced by exogenous agents","volume":"33","author":"Gould","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.therap.2023.09.005_bib0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0404.1990.tb00949.x","article-title":"Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system","volume":"81","author":"Askmark","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.therap.2023.09.005_bib0360","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0305-4179(87)90055-6","article-title":"Carbamazepine-induced facial burns caused by a photocopier","volume":"13","author":"Ward","year":"1987","journal-title":"Burns Incl Therm Inj"},{"key":"10.1016\/j.therap.2023.09.005_bib0365","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1345\/aph.1A007","article-title":"Photopatch testing in seven cases of photosensitive drug eruptions","volume":"35","author":"Lee","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.therap.2023.09.005_bib0370","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.04.003","article-title":"Risk of valproic acid-related alopecia: a systematic review and meta-analysis","volume":"69","author":"Wang","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.therap.2023.09.005_bib0375","unstructured":"Yadav R, Juneja D Antiepileptics-induced alopecia . Principles and practice of critical care toxicology. 2019. https:\/\/www.researchgate.net\/publication\/337559944_Antiepileptics-Induced_Alopecia. [Accessed 12 September 2023]."},{"key":"10.1016\/j.therap.2023.09.005_bib0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yebeh.2014.10.021","article-title":"Cosmetic side effects of antiepileptic drugs in adults with epilepsy","volume":"42","author":"Chen","year":"2015","journal-title":"Epilepsy Behav"},{"year":"2016","series-title":"Diagnostic clinique et imputabilit\u00e9 m\u00e9dicamenteuse de l\u2019\u00e9ryth\u00e8me pigment\u00e9 fixe","author":"Aouina","key":"10.1016\/j.therap.2023.09.005_bib0385"},{"key":"10.1016\/j.therap.2023.09.005_bib0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.seizure.2019.07.003","article-title":"Risks and management of antiepileptic drug induced skin reactions in the adult out-patient setting","volume":"72","author":"Fowler","year":"2019","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.therap.2023.09.005_bib0395","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.braindev.2011.09.003","article-title":"Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis","volume":"34","author":"Mogami","year":"2012","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.therap.2023.09.005_bib0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.therap.2023.09.005_bib0405","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3349\/ymj.2019.60.2.208","article-title":"Analysis of individual case safety reports of severe cutaneous adverse reactions in Korea","volume":"60","author":"Kang","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.therap.2023.09.005_bib0410","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:29:52Z","timestamp":1724344192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595723001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0040595723001415"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2023.09.005","relation":{},"ISSN":["0040-5957"],"issn-type":[{"type":"print","value":"0040-5957"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous adverse effects of antiepileptic drugs","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}